REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmatech Boliviana S.A. (Bolivia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmatech Boliviana S.A. Profile Updated: January 13, 2020
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Pharmatech Boliviana S.A. is based in Bolivia. The head office is in Santa Cruz de la Sierra. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. In its most recent financial highlights, the company reported a net sales revenue drop of 9.72% in 2020. Over the same period, its total assets decreased by 23.58%. The net profit margin of Pharmatech Boliviana S.A. decreased by 0.79% in 2020.

Headquarters
Av. Las Ramblas Edificio: Itc Tower Piso: 4 Zona: Equipetrol
Santa Cruz de la Sierra; Santa Cruz de la Sierra;

Contact Details: Purchase the Pharmatech Boliviana S.A. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharmatech Boliviana S.A. report to view the information.
Financial Auditors:
Purchase the Pharmatech Boliviana S.A. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Financial and Administrative Manager
Company Performance
Financial values in the chart are available after Pharmatech Boliviana S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
-9.72%
Total operating revenue
-9.72%
Operating profit (EBIT)
39.65%
Net Profit (Loss) for the Period
-52.38%
Total assets
-23.58%
Total equity
4.35%
Operating Profit Margin (ROS)
1.78%
Net Profit Margin
-0.79%
Return on Equity (ROE)
-3.58%
Quick Ratio
0.25%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?